Search results for " intestine"

showing 10 items of 132 documents

Age-dependent shift-to-the-right in the localization of colorectal adenomas.

1987

The age-dependent prevalence and topographical distribution of colorectal adenomas was investigated in 1006 unselected autopsies (554 males and 452 females) in Mainz, FRG. In 200 out of 1006 autopsies (19.8%) a total of 498 adenomas of the large intestine were detected. The percentage of patients with adenomas increased continuously with age. Only 6% of all adenomas were localized in the caecum and 8% in the rectum, whereas all the other adenomas were distributed rather evenly throughout the ascending colon (23%), the transverse colon (25%), the descending colon (15%) and the sigmoid colon (23%). Analyzing the topographical distribution of adenomas for definite age groups (40-59, 60-69, 70-…

AdenomaAdultMalemedicine.medical_specialtyendocrine system diseasesAdenomaAdolescentColorectal cancerRectumGastroenterologyPathology and Forensic MedicineDescending colonRisk FactorsInternal medicineMedicineAscending colonHumansLarge intestineMolecular BiologyAgedAged 80 and overbusiness.industryRectal NeoplasmsTransverse colonAge FactorsSigmoid colonCell BiologyGeneral MedicineMiddle Agedmedicine.diseasedigestive system diseasesstomatognathic diseasesmedicine.anatomical_structureColonic NeoplasmsFemalebusinessVirchows Archiv. A, Pathological anatomy and histopathology
researchProduct

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

2013

The Microbiota Makes for Good Therapy The gut microbiota has been implicated in the development of some cancers, such as colorectal cancer, but—given the important role our intestinal habitants play in metabolism—they may also modulate the efficacy of certain cancer therapeutics. Iida et al. (p. 967 ) evaluated the impact of the microbiota on the efficacy of an immunotherapy [CpG (the cytosine, guanosine, phosphodiester link) oligonucleotides] and oxaliplatin, a platinum compound used as a chemotherapeutic. Both therapies were reduced in efficacy in tumor-bearing mice that lacked microbiota, with the microbiota important for activating the innate immune response against the tumors. Viaud et…

Adoptive cell transferCyclophosphamidemedicine.drug_classLymphoid TissueGram-positive bacteria[SDV]Life Sciences [q-bio]AntibioticsAntineoplastic AgentsGut floraGram-Positive BacteriaArticle03 medical and health sciencesMice0302 clinical medicineImmune systemNeoplasmsIntestine SmallmedicineTumor MicroenvironmentGerm-Free LifeAnimalsCyclophosphamide030304 developmental biology0303 health sciencesMultidisciplinarybiology[ SDV ] Life Sciences [q-bio]Microbiotabiology.organism_classificationAdoptive TransferSmall intestine3. Good healthAnti-Bacterial AgentsIntestines[SDV] Life Sciences [q-bio]medicine.anatomical_structureLymphatic system030220 oncology & carcinogenesisBacterial TranslocationImmunologyCancer researchTh17 CellsImmunologic MemoryImmunosuppressive Agentsmedicine.drug
researchProduct

Exogenous glucagon-like peptide-1 reduces contractions in human colon circular muscle.

2014

Glucagon-like peptide 1 (GLP1) is a naturally occurring peptide secreted by intestinal L-cells. Though its primary function is to serve as an incretin, GLP1 reduces gastrointestinal motility. However, only a handful of animal studies have specifically evaluated the influence of GLP1 on colonic motility. Consequently, the aims of this study were to investigate the effects induced by exogenous GLP1, to analyze the mechanism of action, and to verify the presence of GLP1 receptors (GLP1Rs) in human colon circular muscular strips. Organ bath technique, RT-PCR, western blotting, and immunofluorescence were used. In human colon, exogenous GLP1 reduced, in a concentration-dependent manner, the ampl…

AdultMalemedicine.medical_specialtyColonEndocrinology Diabetes and MetabolismIncretinMotilityDown-RegulationIn Vitro TechniquesSettore BIO/09 - FisiologiaGlucagon-Like Peptide-1 ReceptorNitric oxidechemistry.chemical_compoundEndocrinologyGlucagon-Like Peptide 1Internal medicinemedicineReceptors GlucagonHumansLarge intestineReceptorMyenteric plexusAgedAged 80 and overMusclesGLP-1 human colon contractily intestinal motilityMiddle Agedmedicine.anatomical_structureEndocrinologychemistryMechanism of actionTetrodotoxinFemalemedicine.symptomGastrointestinal MotilityMuscle Contraction
researchProduct

Large-scale epidemiological data on vascular disorders of the intestine

2020

Objectives: This article aims to provide updates on the worldwide epidemiology of vascular disorders of the intestine.Methods: A comprehensive search for obtaining worldwide epidemiologic informati...

AdultMalemedicine.medical_specialtyScale (ratio)AdolescentDatabases FactualGlobal Health03 medical and health sciencesYoung Adult0302 clinical medicineAge DistributionEnvironmental healthEpidemiologymedicineHumansVascular DiseasesSex DistributionChildAgedAged 80 and overVascular disorders of the intestineIncidenceGastroenterologyInfant NewbornInfantMiddle AgedmortalityIntestinal DiseasesGeographySocioeconomic Factors030220 oncology & carcinogenesisChild PreschoolVascular disorders of the intestine; epidemiology; mortalityLinear Models030211 gastroenterology & hepatologyFemaleepidemiologyQuality-Adjusted Life Years
researchProduct

Crohn's disease: A comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema

2005

Background: Small intestine contrast ultrasonography (SICUS), when performed after distention of the small bowel lumen with an iso-osmolar polyethylene glycol electrolyte-balanced solution, shows high sensitivity (100%) and specificity (97%) in detecting small bowel abnormalities in patients who have not received a diagnosis but in whom there is a suspicion of intestinal diseases. The diagnostic yield of SICUS remains to be established in detecting small bowel lesions in patients with proven Crohn's disease (CD) in comparison with transabdominal ultrasonography (TUS), and in relationship to the experience of the operator, using small bowel enema (SBE) as the “gold standard.” Aim: The aim of…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentContrast MediaSmall bowel enemaLumen (anatomy)EnemaSensitivity and SpecificityGastroenterologyPolyethylene GlycolsDiagnosis DifferentialJejunumSettore MED/12Professional CompetenceCrohn DiseaseInternal medicineAbdomenIntestine SmallmedicineHumansImmunology and AllergyProspective cohort studyUltrasonographyCrohn's diseaseSicusbiologybusiness.industryGastroenterologyEnemaMiddle AgedSmall bowelmedicine.diseasebiology.organism_classificationSmall intestineCrohn's diseaseStenosismedicine.anatomical_structureSolventsFemalebusinessDilatation Pathologic
researchProduct

Gluten affects epithelial differentiation-associated genes in small intestinal mucosa of coeliac patients

2007

Summary In coeliac disease gluten induces an immunological reaction in genetically susceptible patients, and influences on epithelial cell proliferation and differentiation in the small-bowel mucosa. Our aim was to find novel genes which operate similarly in epithelial proliferation and differentiation in an epithelial cell differentiation model and in coeliac disease patient small-bowel mucosal biopsy samples. The combination of cDNA microarray data originating from a three-dimensional T84 epithelial cell differentiation model and small-bowel mucosal biopsy samples from untreated and treated coeliac disease patients and healthy controls resulted in 30 genes whose mRNA expression was simila…

AdultTranslational StudiesGlutensDuodenummedicine.medical_treatmentCellular differentiationBiopsyImmunologyBiologyCoeliac diseaseGrowth factor receptorIntestinal mucosaGene expressionmedicineImmunology and AllergyHumansRNA MessengerIntestinal MucosaImmunity Mucosalbeta CateninEpithelial cell differentiationAgedOligonucleotide Array Sequence AnalysisReverse Transcriptase Polymerase Chain ReactionGrowth factorGene Expression ProfilingCell DifferentiationEpithelial CellsMiddle Agedmedicine.diseaseSmall intestinedigestive system diseasesWiskott-Aldrich Syndrome Protein FamilyErbB ReceptorsCeliac Diseasemedicine.anatomical_structureGene Expression RegulationImmunology
researchProduct

Pancreatitis-associated protein in patients with celiac disease: Serum levels and immunocytochemical localization in small intestine

1997

Since PAP is a stress protein expressed in human pancreas during pancreatitis but also constitutively synthesized in the small intestine, we looked whether its expression would be altered in patients with celiac disease. Serum PAP concentrations were determined consecutively in 54 patients with celiac disease on a free diet (group A), in 47 patients with celiac disease on a gluten-free diet (group B), in 22 patients with other intestinal pathologies but with normal intestinal mucosa (group C), in 14 patients with retarded growth, no gastrointestinal disease and normal intestinal mucosa (group D), and in 17 controls (group E). Serum PAP levels (ng/ml) were significantly higher in group A (12…

Adultmedicine.medical_specialtyPathologyGlutensBiopsyImmunocytochemistryPancreatitis-Associated ProteinsBiologyGastroenterologyCoeliac diseaseJejunumIntestinal mucosaAntigens NeoplasmLectinsInternal medicineIntestine SmallBiomarkers TumormedicineAnimalsHumansLectins C-TypeIntestinal MucosaPancreatitis-Associated ProteinsChildGastroenterologyAcute-phase proteinInfantmedicine.diseaseImmunohistochemistrySmall intestineImmunoglobulin ACeliac DiseaseJejunummedicine.anatomical_structureChild PreschoolImmunoglobulin GPancreatitisFemaleRabbitsAcute-Phase Proteins
researchProduct

In Vitro Bioavailability of Phenolic Compounds from Five Cultivars of Frozen Sweet Cherries (Prunus aviumL.)

2008

The bioavailability of phenolic compounds from five cultivars of frozen sweet cherries was assessed by a digestion process involving pepsin-HCl digestion (to simulate gastric digestion) and pancreatin digestion with bile salts (to simulate small intestine conditions) and dialyzed to assess serum- and colon-available fractions. After pepsin digestion, the % recovery of total phenolics, relative to the original starting material, increased, whereas the % anthocyanins did not change. Following pancreatic digestion and dialysis, the total phenolics in the IN (serum-available) fraction was about 26–30% and the OUT (colon-available) fraction was about 77–101%. The anthocyanin content in the IN fr…

AnthocyaninBiological AvailabilityFraction (chemistry)In Vitro TechniquescianydinAnthocyaninsfunctional food digestionchemistry.chemical_compoundPrunuscherryPhenolsSpecies SpecificitySettore BIO/10 - BiochimicaFreezingflavonoids total phenolicmedicineCultivarFood scienceChromatography High Pressure Liquidfood and beveragesGeneral ChemistryPepsin AIn vitroSmall intestineBioavailabilitySettore AGR/03 - Arboricoltura Generale E Coltivazioni Arboreemedicine.anatomical_structurechemistryBiochemistryFruitAnthocyaninDigestionHydrochloric AcidPrunusbioavailabilitymaturityGeneral Agricultural and Biological SciencesDigestionripening.Journal of Agricultural and Food Chemistry
researchProduct

Über die pharmakologische Prüfung von 2-Skatyl-alkylpyridinen

1968

2-Skatyl-alkylpyridine wurden an verschiedenen isolierten Organen untersucht. Die Substanzen zeigten am isolierten Rattendarm eine kompetitiv-nichtkompetitive anticholinerge Wirkung, am isolierten Meerschweinchendarm eine kompetitiv-nichtkompetitive Antihistaminwirkung. An isolierten Meerschweinchenvorhofen trat nach Gabe der tertiaren 2-Skatyl-alkylpyridine eine durch Atropin aufzuhebende negativ inotrope Wirkung auf, die quartaren Substanzen waren dagegen positiv inotrop wirksam. Die tertiaren Stoffe wirkten blutdrucksenkend, die quartaren bei kleinen Dosen blutdrucksteigernd, bei hoheren Dosen blutdrucksenkend. 2-Skatyl-alkyl-pyridines have been studied on different isolated organs. The …

AtropineContraction amplitudeRat intestineChemistryStereochemistryDrug DiscoverymedicinePharmaceutical ScienceBlood pressure loweringPharmacologyGuinea pig ileumGuinea pig atriamedicine.drugArchiv der Pharmazie
researchProduct

Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal …

2018

Brachial Plexus Neuritismedicine.medical_specialtybusiness.industryPhases of clinical researchHematologyGastroenterology03 medical and health sciencesLarge Intestine Adenocarcinomachemistry.chemical_compound0302 clinical medicineOncologychemistry030220 oncology & carcinogenesisInternal medicineRegorafenibmedicine030211 gastroenterology & hepatologyColorectal adenocarcinomaIn patientPreviously treatedbusinessAnnals of Oncology
researchProduct